Efficient generation of autologous peripheral blood-derived cytotoxic T lymphocytes against poorly immunogenic human tumors using recombinant CD80-adenovirus together with interleukin 12 and interleukin 2.

Source:http://linkedlifedata.com/resource/pubmed/id/9533541

Download in:

View as

General Info

PMID
9533541